PE
SVRA icon

Point72 Europe’s Savara SVRA Stock Holding History

Point72 Europe’s Portfolio SVRA Stock Details SVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$2.2K Buy
+617
New +$1.82K ﹤0.01% 657

Other funds holding SVRA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Point72 Europe's SVRA Position: Q3 2025 in Review

Point72 Europe opened a new position in Savara (SVRA) in Q3 2025: 617 shares worth $2.2K. The stake represents ﹤0.01% of the portfolio and ranks #657 among its holdings.

125 funds tracked by Wall St. Rank hold SVRA as of Q3 2025.

  • Point72 Europe held 617 shares of Savara worth $2.2K as of Q3 2025.
  • Savara was a new Point72 Europe position in Q3 2025.
  • Savara made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #657 holding.
  • 125 funds tracked by Wall St. Rank held Savara as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.